no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung, Hsiang-Chi |
|
2010 |
28 |
45 |
p. 7337-7343 7 p. |
article |
2 |
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010
|
Vellozzi, Claudia |
|
2010 |
28 |
45 |
p. 7248-7255 8 p. |
article |
3 |
Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)
|
Shearer, Jeffry D. |
|
2010 |
28 |
45 |
p. 7313-7318 6 p. |
article |
4 |
Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities
|
Maher, Lisa |
|
2010 |
28 |
45 |
p. 7273-7278 6 p. |
article |
5 |
Comment on the contribution by Weycker et al., “Cost of routine immunization of young children against rotavirus infection with Rotarix® versus RotaTeq®”
|
Toumi, Mondher |
|
2010 |
28 |
45 |
p. 7241- 1 p. |
article |
6 |
Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice
|
Zhang, Guohong |
|
2010 |
28 |
45 |
p. 7243-7247 5 p. |
article |
7 |
Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination
|
Surls, Jacqueline |
|
2010 |
28 |
45 |
p. 7319-7330 12 p. |
article |
8 |
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
|
Kim, Daejin |
|
2010 |
28 |
45 |
p. 7297-7305 9 p. |
article |
9 |
Editorial Board
|
|
|
2010 |
28 |
45 |
p. CO2- 1 p. |
article |
10 |
Effect of influenza vaccination on hospitalizations in persons aged 50 years and older
|
Baxter, Roger |
|
2010 |
28 |
45 |
p. 7267-7272 6 p. |
article |
11 |
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
|
Tewari, Kavita |
|
2010 |
28 |
45 |
p. 7256-7266 11 p. |
article |
12 |
Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen
|
Shen, Meilong |
|
2010 |
28 |
45 |
p. 7288-7296 9 p. |
article |
13 |
Response to Toumi et al
|
Weycker, Derek |
|
2010 |
28 |
45 |
p. 7242- 1 p. |
article |
14 |
Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis
|
Black, Steven |
|
2010 |
28 |
45 |
p. 7331-7336 6 p. |
article |
15 |
Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment
|
Shahar, Ehud |
|
2010 |
28 |
45 |
p. 7279-7287 9 p. |
article |
16 |
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects
|
Howles, Sarah |
|
2010 |
28 |
45 |
p. 7306-7312 7 p. |
article |